跳至主要内容
临床试验/ISRCTN62859294
ISRCTN62859294已完成未知

A pilot study of the feasibility and patient-related outcomes of performing a walking intervention in patients undergoing treatment for rectal cancer (the REx trial)

HS Greater Glasgow and Clyde (UK)0 个研究点目标入组 80 人开始时间: 2014年3月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30657249 feasibility results (added 21/01/2019) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32564236/ muscle mass results (added 22/06/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Any patient over 18 years of age
  • 2. Independently mobile
  • 3. Has been diagnosed with rectal cancer
  • 4. Planned first line of treatment is chemotherapy and radiotherapy followed by curative surgery
  • (timing at discretion of surgeon, but expected between 10-12 weeks post-CRX)

排除标准

  • 1. Chemotherapy and radiotherapy not first-line treatment
  • 2. Patient has had previous malignancies
  • 3. Significant co-morbidity where inclusion into this trial would put the patient?s health at risk
  • 4. Patient has any mental, physical or psychological impairment that prevents them from giving signed informed consent
  • 5. Patient is already achieving their recommended activity level per week where participation in a walking programme would mean he/she would be exercising at a lower level than normal

研究者

发起方
HS Greater Glasgow and Clyde (UK)

相似试验